BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26208995)

  • 1. Social network analysis of Pseudomonas aeruginosa in cystic fibrosis.
    Taylor-Robinson DC; Southern KW; Winstanley C
    Lancet Respir Med; 2015 Aug; 3(8):595-6. PubMed ID: 26208995
    [No Abstract]   [Full Text] [Related]  

  • 2. The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysis.
    Kidd TJ; Soares Magalhães RJ; Paynter S; Bell SC;
    Lancet Respir Med; 2015 Aug; 3(8):640-50. PubMed ID: 26208994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 1-m distance is not safe for children with cystic fibrosis at risk for cross-infection with Pseudomonas aeruginosa.
    Festini F; Taccetti G; Galici V; Neri S; Bisogni S; Ciofi D; Braggion C
    Am J Infect Control; 2010 Apr; 38(3):244-5. PubMed ID: 20129701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-infection with Pseudomonas aeruginosa among patients with cystic fibrosis.
    Agarwal G; Kapil A; Kabra SK; Das BK
    Natl Med J India; 2006; 19(4):236-7. PubMed ID: 17103494
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics.
    Armstrong D; Bell S; Robinson M; Bye P; Rose B; Harbour C; Lee C; Service H; Nissen M; Syrmis M; Wainwright C
    J Clin Microbiol; 2003 May; 41(5):2266-7. PubMed ID: 12734299
    [No Abstract]   [Full Text] [Related]  

  • 6. Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients.
    Tümmler B; Koopmann U; Grothues D; Weissbrodt H; Steinkamp G; von der Hardt H
    J Clin Microbiol; 1991 Jun; 29(6):1265-7. PubMed ID: 1907611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital epidemiology of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Speert DP; Campbell ME
    J Hosp Infect; 1987 Jan; 9(1):11-21. PubMed ID: 2880893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives.
    McCallum SJ; Gallagher MJ; Corkill JE; Hart CA; Ledson MJ; Walshaw MJ
    Thorax; 2002 Jun; 57(6):559-60. PubMed ID: 12037234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas cepacia in cystic fibrosis patients.
    Prince A
    Am Rev Respir Dis; 1986 Oct; 134(4):644-5. PubMed ID: 3094414
    [No Abstract]   [Full Text] [Related]  

  • 10. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic.
    Jones AM; Govan JR; Doherty CJ; Dodd ME; Isalska BJ; Stanbridge TN; Webb AK
    Lancet; 2001 Aug; 358(9281):557-8. PubMed ID: 11520529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas cross-infection from cystic fibrosis patients to non-cystic fibrosis patients: implications for inpatient care of respiratory patients.
    Robinson P; Carzino R; Armstrong D; Olinsky A
    J Clin Microbiol; 2003 Dec; 41(12):5741. PubMed ID: 14662972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis unit.
    Denton M; Littlewood JM; Brownlee KG; Conway SP; Todd NJ
    Lancet; 1996 Dec; 348(9041):1596-7. PubMed ID: 8950918
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review?
    Høiby N; Johansen HK
    J Hosp Infect; 2007 Apr; 65(4):374-5; author reply 375-6. PubMed ID: 17275952
    [No Abstract]   [Full Text] [Related]  

  • 14. Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in a cystic fibrosis clinic.
    Zimakoff J; Høiby N; Rosendal K; Guilbert JP
    J Hosp Infect; 1983 Mar; 4(1):31-40. PubMed ID: 6190882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How and why to monitor Pseudomonas aeruginosa infections in the long term at a cystic fibrosis centre.
    Kalferstova L; Vilimovska Dedeckova K; Antuskova M; Melter O; Drevinek P
    J Hosp Infect; 2016 Jan; 92(1):54-60. PubMed ID: 26597636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does pseudomonas cross-infection occur between cystic-fibrosis patients.
    Kelly NM; Fitzgerald MX; Tempany E; O'Boyle C; Falkiner FR; Keane CT
    Lancet; 1982 Sep; 2(8300):688-90. PubMed ID: 6126629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Communicability of Pseudomonas infections in patients with cystic fibrosis.
    Speert DP; Davidson AG; Wong LT; Paranchych W
    J Pediatr; 1989 Jun; 114(6):1068-9. PubMed ID: 2723904
    [No Abstract]   [Full Text] [Related]  

  • 18. Pseudomonas cepacia in cystic fibrosis: transmissibility and its implications.
    Walters S; Smith EG
    Lancet; 1993 Jul; 342(8862):3-4. PubMed ID: 7686240
    [No Abstract]   [Full Text] [Related]  

  • 19. Communicability of Pseudomonas aeruginosa in a cystic fibrosis summer camp.
    Speert DP; Lawton D; Damm S
    J Pediatr; 1982 Aug; 101(2):227-8. PubMed ID: 6808106
    [No Abstract]   [Full Text] [Related]  

  • 20. Pseudomonas aeruginosa cross-infection in cystic fibrosis.
    Jones AM; Webb AK; Govan JR; Hart CA; Walshaw MJ
    Lancet; 2002 Feb; 359(9305):527-8. PubMed ID: 11853828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.